In breast cancer, RB1 is lost primarily in TNBC and most commonly in the BL1 subtype, which also exhibits high E2F1 and E2F2 expression as well as TP53 mutation, PTEN loss and high MYC, WNT and RHOA signaling [34]. Here, MYC is linked to breast carcinoma.